+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

High-throughput Oligonucleotide Synthesizers Market - Global Forecast 2026-2032

  • Report

  • 199 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6120852
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The High-throughput Oligonucleotide Synthesizers Market is projected to reach USD 663.72 Million in 2026. It is expected to continue growing at a CAGR of 7.20%, reaching USD 1.01 Billion by 2032.

High-Throughput Oligonucleotide Synthesizers: Executive Overview

High-throughput oligonucleotide synthesizers support the parallel production of DNA and RNA sequences for genomics, molecular diagnostics, drug discovery, synthetic biology, and life-science research. Their value is linked to automated cycle control, sequence flexibility, quality assurance, and the ability to integrate synthesis with purification, analytics, and laboratory information systems. Adoption is shaped by demand for faster experimental iteration, reproducible workflows, and scalable handling of increasingly diverse sequence libraries.

Automation and Workflow Integration Are Reshaping Synthesis

The landscape is shifting from standalone instruments toward connected, workflow-oriented platforms. Greater automation can reduce manual transfers, standardize reagent handling, and improve traceability across synthesis, cleanup, quality control, and storage. Modular configurations are also becoming important because laboratories differ in throughput, sequence length, chemistry, and application requirements. At the same time, users are placing more emphasis on contamination control, waste management, reagent efficiency, serviceability, and compliance-ready documentation.

Artificial Intelligence Strengthens Design, Scheduling, and Quality Control

Artificial intelligence is extending its influence across the oligonucleotide workflow rather than replacing core synthesis chemistry. Machine-learning methods can assist sequence design, identify problematic motifs, prioritize experimental conditions, and support prediction of synthesis-related impurities. Within operations, AI-enabled monitoring may help detect process deviations, optimize scheduling, and flag quality-control anomalies earlier. Effective adoption still depends on representative training data, explainable outputs, validated decision rules, cybersecurity, and human review for regulated or high-consequence applications.

Regional Insights: Adoption Reflects Research Capacity and Infrastructure

North America benefits from strong biotechnology, pharmaceutical, academic, and genomics ecosystems, supporting demand for automated synthesis and integrated analytical workflows. Europe combines advanced research capacity with rigorous requirements for quality, traceability, sustainability, and data governance. Asia-Pacific is driven by expanding molecular research, biomanufacturing capabilities, and investments in genomics and synthetic biology, although infrastructure and procurement conditions vary widely. Latin America shows opportunity where diagnostic, agricultural, and academic programs are strengthening, but access to specialized equipment, technical support, and financing remains uneven. The Middle East is developing life-science and translational research infrastructure, while Africa’s progress is concentrated in centers with established genomics, public-health, and university capabilities.

Group Insights: Economic and Institutional Blocs Shape Capability Building

ASEAN countries are developing complementary strengths in biomedical research, manufacturing, and regional laboratory networks, with adoption influenced by import procedures, technical training, and local service availability. BRICS economies combine substantial scientific capacity with varied regulatory, infrastructure, and procurement environments, creating distinct pathways for domestic capability building. The European Union emphasizes harmonized research standards, laboratory quality, sustainability, and cross-border collaboration. G7 members generally have mature research and pharmaceutical ecosystems, supporting advanced automation and data integration. GCC states are investing in healthcare, genomics, and research infrastructure, while NATO members reflect a broad set of established and emerging capabilities shaped by resilience, security, and supply-chain considerations.

Country Insights: National Priorities Determine Deployment Patterns

Australia supports adoption through genomics, medical research, and agricultural science, while Brazil and Mexico are strengthening molecular research and diagnostic capacity amid infrastructure and procurement constraints. Canada combines public research strength with biotechnology activity and geographically dispersed laboratory networks. China, India, Japan, and South Korea are advancing genomics, biopharmaceutical research, and domestic laboratory capabilities, with differences in scale, standards, and supply-chain localization. France, Germany, Italy, Spain, and the United Kingdom benefit from established academic, clinical, and industrial research bases, with particular attention to quality systems, automation, and regulatory alignment. Russia’s capabilities reflect its scientific institutions and domestic procurement priorities, while access to international equipment, reagents, and service networks can influence deployment and continuity.

Actions for Leaders: Build Flexible, Validated, and Serviceable Platforms

Industry leaders should match instrument configuration to actual sequence, plate, chemistry, and quality-control requirements rather than optimizing for nominal throughput alone. Priorities include open integration interfaces, validated automation, robust contamination controls, secure data handling, and clear upgrade paths. Buyers should evaluate total workflow performance, consumable continuity, preventive maintenance, operator training, and local technical support. Organizations can improve resilience by qualifying alternative suppliers where feasible, documenting critical process parameters, and establishing governance for AI-assisted design or monitoring. Collaboration with academic, clinical, and manufacturing users can also help align platform development with real laboratory bottlenecks.

Research Methodology: Evidence-Led Assessment of Technology and Adoption Drivers

This executive summary uses a structured assessment of high-throughput oligonucleotide synthesis across applications, workflows, enabling technologies, infrastructure, regulation, and regional capability. Analysis distinguishes instrument functionality from broader laboratory adoption and considers publicly documented developments in automation, genomics, synthetic biology, diagnostics, biopharmaceutical research, and quality management. Regional, group, and country narratives synthesize institutional capacity, research intensity, manufacturing development, procurement conditions, and operational constraints. No market estimates, market shares, forecasts, or company-specific claims are used.

Conclusion: Scalable Synthesis Depends on Integrated Capability

High-throughput oligonucleotide synthesizers are becoming strategic components of automated molecular workflows. Their impact depends not only on parallel synthesis capacity, but also on sequence-design support, analytical confidence, software interoperability, service infrastructure, and responsible data practices. Regional and national differences will continue to shape deployment, yet the common direction is clear: laboratories are seeking reproducible, flexible, and traceable systems that can connect synthesis with the broader research and biomanufacturing process.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. High-throughput Oligonucleotide Synthesizers Market, by Chemistry
7.1. Introduction
7.2. DNA
7.3. Modified
7.3.1. 2'-O-Methyl
7.3.2. Locked Nucleic Acid
7.3.3. Phosphorothioate
7.4. RNA
8. High-throughput Oligonucleotide Synthesizers Market, by Synthesizer Type
8.1. Introduction
8.2. Batch Synthesizer
8.3. Continuous Flow Synthesizer
8.4. Microarray Synthesizer
9. High-throughput Oligonucleotide Synthesizers Market, by Throughput
9.1. Introduction
9.2. High Throughput
9.3. Low Throughput
9.4. Medium Throughput
10. High-throughput Oligonucleotide Synthesizers Market, by Application
10.1. Introduction
10.2. Clinical Diagnostics
10.3. Research Use
10.4. Therapeutic Development
11. High-throughput Oligonucleotide Synthesizers Market, by End User
11.1. Introduction
11.2. Academic & Research Institutes
11.3. Contract Research Organizations
11.4. Diagnostic Laboratories
11.5. Pharmaceutical & Biotechnology Companies
12. High-throughput Oligonucleotide Synthesizers Market, by Sales Channel
12.1. Introduction
12.2. Online
12.3. Offline
13. High-throughput Oligonucleotide Synthesizers Market, by Region
13.1. Introduction
13.2. Asia-Pacific
13.3. North America
13.4. Latin America
13.5. Europe
13.6. Middle East
13.7. Africa
14. High-throughput Oligonucleotide Synthesizers Market, by Group
14.1. Introduction
14.2. ASEAN
14.3. GCC
14.4. European Union
14.5. BRICS
14.6. G7
14.7. NATO
15. High-throughput Oligonucleotide Synthesizers Market, by Country
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. United Kingdom
15.7. Germany
15.8. France
15.9. Russia
15.10. Italy
15.11. Spain
15.12. China
15.13. India
15.14. Japan
15.15. Australia
15.16. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. Market Concentration Analysis, 2025
16.2.1. Concentration Ratio (CR)
16.2.2. Herfindahl Hirschman Index (HHI)
16.3. Recent Developments & Impact Analysis, 2025
16.4. Product Portfolio Analysis, 2025
16.5. Benchmarking Analysis, 2025
17. Company Profiles
17.1. Agilent Technologies, Inc.
17.2. Biolytic Lab Performance, Inc.
17.3. Bioneer Corporation
17.4. Biosearch Technologies, Inc.
17.5. Cantio Bio, Inc.
17.6. CSBio
17.7. Cytiva Life Sciences
17.8. Danaher Corporation
17.9. DNA Script
17.10. Eurofins Scientific SE
17.11. GenScript Biotech Corporation
17.12. Integrated DNA Technologies, Inc.
17.13. Kaneka Eurogentec S.A.
17.14. Kilobaser
17.15. LGC Limited
17.16. Merck KGaA
17.17. Nitto Denko Avecia Inc.
17.18. OligoMaker ApS
17.19. PolyGen GmbH
17.20. Revvity Discovery Limited
17.21. Sierra BioSystems, Inc.
17.22. Thermo Fisher Scientific Inc.
17.23. TriLink BioTechnologies, LLC
17.24. Twist Bioscience Corporation
18. Key Experts
LIST OF FIGURES
FIGURE 1. Global High-throughput Oligonucleotide Synthesizers Market, Years Considered for the Study
FIGURE 2. Global High-throughput Oligonucleotide Synthesizers Market, Research Design
FIGURE 3. Global High-throughput Oligonucleotide Synthesizers Market, Research Framework
FIGURE 4. Global High-throughput Oligonucleotide Synthesizers Market, Data Triangulation
FIGURE 5. Global High-throughput Oligonucleotide Synthesizers Market Size, 2017-2032 (USD Million)
FIGURE 6. Global High-throughput Oligonucleotide Synthesizers Market Size, by Chemistry, 2025 vs 2032 (%)
FIGURE 7. Global High-throughput Oligonucleotide Synthesizers Market Size, by Chemistry, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global High-throughput Oligonucleotide Synthesizers Market Size, by Synthesizer Type, 2025 vs 2032 (%)
FIGURE 9. Global High-throughput Oligonucleotide Synthesizers Market Size, by Synthesizer Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global High-throughput Oligonucleotide Synthesizers Market Size, by Throughput, 2025 vs 2032 (%)
FIGURE 11. Global High-throughput Oligonucleotide Synthesizers Market Size, by Throughput, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global High-throughput Oligonucleotide Synthesizers Market Size, by Application, 2025 vs 2032 (%)
FIGURE 13. Global High-throughput Oligonucleotide Synthesizers Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global High-throughput Oligonucleotide Synthesizers Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global High-throughput Oligonucleotide Synthesizers Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global High-throughput Oligonucleotide Synthesizers Market Size, by Sales Channel, 2025 vs 2032 (%)
FIGURE 17. Global High-throughput Oligonucleotide Synthesizers Market Size, by Sales Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global High-throughput Oligonucleotide Synthesizers Market Size, by Region, 2025 vs 2032 (%)
FIGURE 19. Global High-throughput Oligonucleotide Synthesizers Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global High-throughput Oligonucleotide Synthesizers Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global High-throughput Oligonucleotide Synthesizers Market Size, by Country, 2025 vs 2032 (%)
FIGURE 22. Global High-throughput Oligonucleotide Synthesizers Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 23. Global High-throughput Oligonucleotide Synthesizers Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global High-throughput Oligonucleotide Synthesizers Market Segmentation & Coverage
TABLE 2. Global High-throughput Oligonucleotide Synthesizers Market Size, 2017-2032 (USD Million)
TABLE 3. Global High-throughput Oligonucleotide Synthesizers Market Size, by Chemistry, 2017-2032 (USD Million)
TABLE 4. Global DNA Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global DNA Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global DNA Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Modified Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Modified Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Modified Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global 2'-O-Methyl Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global 2'-O-Methyl Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global 2'-O-Methyl Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Locked Nucleic Acid Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Locked Nucleic Acid Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Locked Nucleic Acid Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Phosphorothioate Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Phosphorothioate Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Phosphorothioate Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global RNA Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global RNA Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global RNA Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global High-throughput Oligonucleotide Synthesizers Market Size, by Synthesizer Type, 2017-2032 (USD Million)
TABLE 23. Global Batch Synthesizer Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Batch Synthesizer Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Batch Synthesizer Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Continuous Flow Synthesizer Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Continuous Flow Synthesizer Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Continuous Flow Synthesizer Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Microarray Synthesizer Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Microarray Synthesizer Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Microarray Synthesizer Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global High-throughput Oligonucleotide Synthesizers Market Size, by Throughput, 2017-2032 (USD Million)
TABLE 33. Global High Throughput Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global High Throughput Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global High Throughput Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global Low Throughput Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Low Throughput Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Low Throughput Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Medium Throughput Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Medium Throughput Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Medium Throughput Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global High-throughput Oligonucleotide Synthesizers Market Size, by Application, 2017-2032 (USD Million)
TABLE 43. Global Clinical Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Clinical Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Clinical Diagnostics Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Research Use Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Research Use Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Research Use Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Therapeutic Development Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Therapeutic Development Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Therapeutic Development Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global High-throughput Oligonucleotide Synthesizers Market Size, by End User, 2017-2032 (USD Million)
TABLE 53. Global Academic & Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Academic & Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Academic & Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Contract Research Organizations Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Contract Research Organizations Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Contract Research Organizations Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Diagnostic Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Diagnostic Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Diagnostic Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Pharmaceutical & Biotechnology Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Pharmaceutical & Biotechnology Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Pharmaceutical & Biotechnology Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global High-throughput Oligonucleotide Synthesizers Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 66. Global Online Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Global Online Market Size, by Group, 2017-2032 (USD Million)
TABLE 68. Global Online Market Size, by Country, 2017-2032 (USD Million)
TABLE 69. Global Offline Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Global Offline Market Size, by Group, 2017-2032 (USD Million)
TABLE 71. Global Offline Market Size, by Country, 2017-2032 (USD Million)
TABLE 72. Global High-throughput Oligonucleotide Synthesizers Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Asia-Pacific High-throughput Oligonucleotide Synthesizers Market Size, by Region, 2017-2032 (USD Million)
TABLE 74. Asia-Pacific High-throughput Oligonucleotide Synthesizers Market Size, by Chemistry, 2017-2032 (USD Million)
TABLE 75. Asia-Pacific High-throughput Oligonucleotide Synthesizers Market Size, by Modified, 2017-2032 (USD Million)
TABLE 76. Asia-Pacific High-throughput Oligonucleotide Synthesizers Market Size, by Synthesizer Type, 2017-2032 (USD Million)
TABLE 77. Asia-Pacific High-throughput Oligonucleotide Synthesizers Market Size, by Throughput, 2017-2032 (USD Million)
TABLE 78. Asia-Pacific High-throughput Oligonucleotide Synthesizers Market Size, by Application, 2017-2032 (USD Million)
TABLE 79. Asia-Pacific High-throughput Oligonucleotide Synthesizers Market Size, by End User, 2017-2032 (USD Million)
TABLE 80. Asia-Pacific High-throughput Oligonucleotide Synthesizers Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 81. North America High-throughput Oligonucleotide Synthesizers Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. North America High-throughput Oligonucleotide Synthesizers Market Size, by Chemistry, 2017-2032 (USD Million)
TABLE 83. North America High-throughput Oligonucleotide Synthesizers Market Size, by Modified, 2017-2032 (USD Million)
TABLE 84. North America High-throughput Oligonucleotide Synthesizers Market Size, by Synthesizer Type, 2017-2032 (USD Million)
TABLE 85. North America High-throughput Oligonucleotide Synthesizers Market Size, by Throughput, 2017-2032 (USD Million)
TABLE 86. North America High-throughput Oligonucleotide Synthesizers Market Size, by Application, 2017-2032 (USD Million)
TABLE 87. North America High-throughput Oligonucleotide Synthesizers Market Size, by End User, 2017-2032 (USD Million)
TABLE 88. North America High-throughput Oligonucleotide Synthesizers Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 89. Latin America High-throughput Oligonucleotide Synthesizers Market Size, by Region, 2017-2032 (USD Million)
TABLE 90. Latin America High-throughput Oligonucleotide Synthesizers Market Size, by Chemistry, 2017-2032 (USD Million)
TABLE 91. Latin America High-throughput Oligonucleotide Synthesizers Market Size, by Modified, 2017-2032 (USD Million)
TABLE 92. Latin America High-throughput Oligonucleotide Synthesizers Market Size, by Synthesizer Type, 2017-2032 (USD Million)
TABLE 93. Latin America High-throughput Oligonucleotide Synthesizers Market Size, by Throughput, 2017-2032 (USD Million)
TABLE 94. Latin America High-throughput Oligonucleotide Synthesizers Market Size, by Application, 2017-2032 (USD Million)
TABLE 95. Latin America High-throughput Oligonucleotide Synthesizers Market Size, by End User, 2017-2032 (USD Million)
TABLE 96. Latin America High-throughput Oligonucleotide Synthesizers Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 97. Europe High-throughput Oligonucleotide Synthesizers Market Size, by Region, 2017-2032 (USD Million)
TABLE 98. Europe High-throughput Oligonucleotide Synthesizers Market Size, by Chemistry, 2017-2032 (USD Million)
TABLE 99. Europe High-throughput Oligonucleotide Synthesizers Market Size, by Modified, 2017-2032 (USD Million)
TABLE 100. Europe High-throughput Oligonucleotide Synthesizers Market Size, by Synthesizer Type, 2017-2032 (USD Million)
TABLE 101. Europe High-throughput Oligonucleotide Synthesizers Market Size, by Throughput, 2017-2032 (USD Million)
TABLE 102. Europe High-throughput Oligonucleotide Synthesizers Market Size, by Application, 2017-2032 (USD Million)
TABLE 103. Europe High-throughput Oligonucleotide Synthesizers Market Size, by End User, 2017-2032 (USD Million)
TABLE 104. Europe High-throughput Oligonucleotide Synthesizers Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 105. Middle East High-throughput Oligonucleotide Synthesizers Market Size, by Region, 2017-2032 (USD Million)
TABLE 106. Middle East High-throughput Oligonucleotide Synthesizers Market Size, by Chemistry, 2017-2032 (USD Million)
TABLE 107. Middle East High-throughput Oligonucleotide Synthesizers Market Size, by Modified, 2017-2032 (USD Million)
TABLE 108. Middle East High-throughput Oligonucleotide Synthesizers Market Size, by Synthesizer Type, 2017-2032 (USD Million)
TABLE 109. Middle East High-throughput Oligonucleotide Synthesizers Market Size, by Throughput, 2017-2032 (USD Million)
TABLE 110. Middle East High-throughput Oligonucleotide Synthesizers Market Size, by Application, 2017-2032 (USD Million)
TABLE 111. Middle East High-throughput Oligonucleotide Synthesizers Market Size, by End User, 2017-2032 (USD Million)
TABLE 112. Middle East High-throughput Oligonucleotide Synthesizers Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 113. Africa High-throughput Oligonucleotide Synthesizers Market Size, by Region, 2017-2032 (USD Million)
TABLE 114. Africa High-throughput Oligonucleotide Synthesizers Market Size, by Chemistry, 2017-2032 (USD Million)
TABLE 115. Africa High-throughput Oligonucleotide Synthesizers Market Size, by Modified, 2017-2032 (USD Million)
TABLE 116. Africa High-throughput Oligonucleotide Synthesizers Market Size, by Synthesizer Type, 2017-2032 (USD Million)
TABLE 117. Africa High-throughput Oligonucleotide Synthesizers Market Size, by Throughput, 2017-2032 (USD Million)
TABLE 118. Africa High-throughput Oligonucleotide Synthesizers Market Size, by Application, 2017-2032 (USD Million)
TABLE 119. Africa High-throughput Oligonucleotide Synthesizers Market Size, by End User, 2017-2032 (USD Million)
TABLE 120. Africa High-throughput Oligonucleotide Synthesizers Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 121. Global High-throughput Oligonucleotide Synthesizers Market Size, by Group, 2017-2032 (USD Million)
TABLE 122. ASEAN High-throughput Oligonucleotide Synthesizers Market Size, by Group, 2017-2032 (USD Million)
TABLE 123. ASEAN High-throughput Oligonucleotide Synthesizers Market Size, by Chemistry, 2017-2032 (USD Million)
TABLE 124. ASEAN High-throughput Oligonucleotide Synthesizers Market Size, by Modified, 2017-2032 (USD Million)
TABLE 125. ASEAN High-throughput Oligonucleotide Synthesizers Market Size, by Synthesizer Type, 2017-2032 (USD Million)
TABLE 126. ASEAN High-throughput Oligonucleotide Synthesizers Market Size, by Throughput, 2017-2032 (USD Million)
TABLE 127. ASEAN High-throughput Oligonucleotide Synthesizers Market Size, by Application, 2017-2032 (USD Million)
TABLE 128. ASEAN High-throughput Oligonucleotide Synthesizers Market Size, by End User, 2017-2032 (USD Million)
TABLE 129. ASEAN High-throughput Oligonucleotide Synthesizers Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 130. GCC High-throughput Oligonucleotide Synthesizers Market Size, by Group, 2017-2032 (USD Million)
TABLE 131. GCC High-throughput Oligonucleotide Synthesizers Market Size, by Chemistry, 2017-2032 (USD Million)
TABLE 132. GCC High-throughput Oligonucleotide Synthesizers Market Size, by Modified, 2017-2032 (USD Million)
TABLE 133. GCC High-throughput Oligonucleotide Synthesizers Market Size, by Synthesizer Type, 2017-2032 (USD Million)
TABLE 134. GCC High-throughput Oligonucleotide Synthesizers Market Size, by Throughput, 2017-2032 (USD Million)
TABLE 135. GCC High-throughput Oligonucleotide Synthesizers Market Size, by Application, 2017-2032 (USD Million)
TABLE 136. GCC High-throughput Oligonucleotide Synthesizers Market Size, by End User, 2017-2032 (USD Million)
TABLE 137. GCC High-throughput Oligonucleotide Synthesizers Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 138. European Union High-throughput Oligonucleotide Synthesizers Market Size, by Group, 2017-2032 (USD Million)
TABLE 139. European Union High-throughput Oligonucleotide Synthesizers Market Size, by Chemistry, 2017-2032 (USD Million)
TABLE 140. European Union High-throughput Oligonucleotide Synthesizers Market Size, by Modified, 2017-2032 (USD Million)
TABLE 141. European Union High-throughput Oligonucleotide Synthesizers Market Size, by Synthesizer Type, 2017-2032 (USD Million)
TABLE 142. European Union High-throughput Oligonucleotide Synthesizers Market Size, by Throughput, 2017-2032 (USD Million)
TABLE 143. European Union High-throughput Oligonucleotide Synthesizers Market Size, by Application, 2017-2032 (USD Million)
TABLE 144. European Union High-throughput Oligonucleotide Synthesizers Market Size, by End User, 2017-2032 (USD Million)
TABLE 145. European Union High-throughput Oligonucleotide Synthesizers Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 146. BRICS High-throughput Oligonucleotide Synthesizers Market Size, by Group, 2017-2032 (USD Million)
TABLE 147. BRICS High-throughput Oligonucleotide Synthesizers Market Size, by Chemistry, 2017-2032 (USD Million)
TABLE 148. BRICS High-throughput Oligonucleotide Synthesizers Market Size, by Modified, 2017-2032 (USD Million)
TABLE 149. BRICS High-throughput Oligonucleotide Synthesizers Market Size, by Synthesizer Type, 2017-2032 (USD Million)
TABLE 150. BRICS High-throughput Oligonucleotide Synthesizers Market Size, by Throughput, 2017-2032 (USD Million)
TABLE 151. BRICS High-throughput Oligonucleotide Synthesizers Market Size, by Application, 2017-2032 (USD Million)
TABLE 152. BRICS High-throughput Oligonucleotide Synthesizers Market Size, by End User, 2017-2032 (USD Million)
TABLE 153. BRICS High-throughput Oligonucleotide Synthesizers Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 154. G7 High-throughput Oligonucleotide Synthesizers Market Size, by Group, 2017-2032 (USD Million)
TABLE 155. G7 High-throughput Oligonucleotide Synthesizers Market Size, by Chemistry, 2017-2032 (USD Million)
TABLE 156. G7 High-throughput Oligonucleotide Synthesizers Market Size, by Modified, 2017-2032 (USD Million)
TABLE 157. G7 High-throughput Oligonucleotide Synthesizers Market Size, by Synthesizer Type, 2017-2032 (USD Million)
TABLE 158. G7 High-throughput Oligonucleotide Synthesizers Market Size, by Throughput, 2017-2032 (USD Million)
TABLE 159. G7 High-throughput Oligonucleotide Synthesizers Market Size, by Application, 2017-2032 (USD Million)
TABLE 160. G7 High-throughput Oligonucleotide Synthesizers Market Size, by End User, 2017-2032 (USD Million)
TABLE 161. G7 High-throughput Oligonucleotide Synthesizers Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 162. NATO High-throughput Oligonucleotide Synthesizers Market Size, by Group, 2017-2032 (USD Million)
TABLE 163. NATO High-throughput Oligonucleotide Synthesizers Market Size, by Chemistry, 2017-2032 (USD Million)
TABLE 164. NATO High-throughput Oligonucleotide Synthesizers Market Size, by Modified, 2017-2032 (USD Million)
TABLE 165. NATO High-throughput Oligonucleotide Synthesizers Market Size, by Synthesizer Type, 2017-2032 (USD Million)
TABLE 166. NATO High-throughput Oligonucleotide Synthesizers Market Size, by Throughput, 2017-2032 (USD Million)
TABLE 167. NATO High-throughput Oligonucleotide Synthesizers Market Size, by Application, 2017-2032 (USD Million)
TABLE 168. NATO High-throughput Oligonucleotide Synthesizers Market Size, by End User, 2017-2032 (USD Million)
TABLE 169. NATO High-throughput Oligonucleotide Synthesizers Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 170. Global High-throughput Oligonucleotide Synthesizers Market Size, by Country, 2017-2032 (USD Million)
TABLE 171. United States High-throughput Oligonucleotide Synthesizers Market Size, 2017-2032 (USD Million)
TABLE 172. United States High-throughput Oligonucleotide Synthesizers Market Size, by Chemistry, 2017-2032 (USD Million)
TABLE 173. United States High-throughput Oligonucleotide Synthesizers Market Size, by Modified, 2017-2032 (USD Million)
TABLE 174. United States High-throughput Oligonucleotide Synthesizers Market Size, by Synthesizer Type, 2017-2032 (USD Million)
TABLE 175. United States High-throughput Oligonucleotide Synthesizers Market Size, by Throughput, 2017-2032 (USD Million)
TABLE 176. United States High-throughput Oligonucleotide Synthesizers Market Size, by Application, 2017-2032 (USD Million)
TABLE 177. United States High-throughput Oligonucleotide Synthesizers Market Size, by End User, 2017-2032 (USD Million)
TABLE 178. United States High-throughput Oligonucleotide Synthesizers Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 179. Canada High-throughput Oligonucleotide Synthesizers Market Size, 2017-2032 (USD Million)
TABLE 180. Canada High-throughput Oligonucleotide Synthesizers Market Size, by Chemistry, 2017-2032 (USD Million)
TABLE 181. Canada High-throughput Oligonucleotide Synthesizers Market Size, by Modified, 2017-2032 (USD Million)
TABLE 182. Canada High-throughput Oligonucleotide Synthesizers Market Size, by Synthesizer Type, 2017-2032 (USD Million)
TABLE 183. Canada High-throughput Oligonucleotide Synthesizers Market Size, by Throughput, 2017-2032 (USD Million)
TABLE 184. Canada High-throughput Oligonucleotide Synthesizers Market Size, by Application, 2017-2032 (USD Million)
TABLE 185. Canada High-throughput Oligonucleotide Synthesizers Market Size, by End User, 2017-2032 (USD Million)
TABLE 186. Canada High-throughput Oligonucleotide Synthesizers Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 187. Mexico High-throughput Oligonucleotide Synthesizers Market Size, 2017-2032 (USD Million)
TABLE 188. Mexico High-throughput Oligonucleotide Synthesizers Market Size, by Chemistry, 2017-2032 (USD Million)
TABLE 189. Mexico High-throughput Oligonucleotide Synthesizers Market Size, by Modified, 2017-2032 (USD Million)
TABLE 190. Mexico High-throughput Oligonucleotide Synthesizers Market Size, by Synthesizer Type, 2017-2032 (USD Million)
TABLE 191. Mexico High-throughput Oligonucleotide Synthesizers Market Size, by Throughput, 2017-2032 (USD Million)
TABLE 192. Mexico High-throughput Oligonucleotide Synthesizers Market Size, by Application, 2017-2032 (USD Million)
TABLE 193. Mexico High-throughput Oligonucleotide Synthesizers Market Size, by End User, 2017-2032 (USD Million)
TABLE 194. Mexico High-throughput Oligonucleotide Synthesizers Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 195. Brazil High-throughput Oligonucleotide Synthesizers Market Size, 2017-2032 (USD Million)
TABLE 196. Brazil High-throughput Oligonucleotide Synthesizers Market Size, by Chemistry, 2017-2032 (USD Million)
TABLE 197. Brazil High-throughput Oligonucleotide Synthesizers Market Size, by Modified, 2017-2032 (USD Million)
TABLE 198. Brazil High-throughput Oligonucleotide Synthesizers Market Size, by Synthesizer Type, 2017-2032 (USD Million)
TABLE 199. Brazil High-throughput Oligonucleotide Synthesizers Market Size, by Throughput, 2017-2032 (USD Million)
TABLE 200. Brazil High-throughput Oligonucleotide Synthesizers Market Size, by Application, 2017-2032 (USD Million)
TABLE 201. Brazil High-throughput Oligonucleotide Synthesizers Market Size, by End User, 2017-2032 (USD Million)
TABLE 202. Brazil High-throughput Oligonucleotide Synthesizers Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 203. United Kingdom High-throughput Oligonucleotide Synthesizers Market Size, 2017-2032 (USD Million)
TABLE 204. United Kingdom High-throughput Oligonucleotide Synthesizers Market Size, by Chemistry, 2017-2032 (USD Million)
TABLE 205. United Kingdom High-throughput Oligonucleotide Synthesizers Market Size, by Modified, 2017-2032 (USD Million)
TABLE 206. United Kingdom High-throughput Oligonucleotide Synthesizers Market Size, by Synthesizer Type, 2017-2032 (USD Million)
TABLE 207. United Kingdom High-throughput Oligonucleotide Synthesizers Market Size, by Throughput, 2017-2032 (USD Million)
TABLE 208. United Kingdom High-throughput Oligonucleotide Synthesizers Market Size, by Application, 2017-2032 (USD Million)
TABLE 209. United Kingdom High-throughput Oligonucleotide Synthesizers Market Size, by End User, 2017-2032 (USD Million)
TABLE 210. United Kingdom High-throughput Oligonucleotide Synthesizers Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 211. Germany High-throughput Oligonucleotide Synthesizers Market Size, 2017-2032 (USD Million)
TABLE 212. Germany High-throughput Oligonucleotide Synthesizers Market Size, by Chemistry, 2017-2032 (USD Million)
TABLE 213. Germany High-throughput Oligonucleotide Synthesizers Market Size, by Modified, 2017-2032 (USD Million)
TABLE 214. Germany High-throughput Oligonucleotide Synthesizers Market Size, by Synthesizer Type, 2017-2032 (USD Million)
TABLE 215. Germany High-throughput Oligonucleotide Synthesizers Market Size, by Throughput, 2017-2032 (USD Million)
TABLE 216. Germany High-throughput Oligonucleotide Synthesizers Market Size, by Application, 2017-2032 (USD Million)
TABLE 217. Germany High-throughput Oligonucleotide Synthesizers Market Size, by End User, 2017-2032 (USD Million)
TABLE 218. Germany High-throughput Oligonucleotide Synthesizers Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 219. France High-throughput Oligonucleotide Synthesizers Market Size, 2017-2032 (USD Million)
TABLE 220. France High-throughput Oligonucleotide Synthesizers Market Size, by Chemistry, 2017-2032 (USD Million)
TABLE 221. France High-throughput Oligonucleotide Synthesizers Market Size, by Modified, 2017-2032 (USD Million)
TABLE 222. France High-throughput Oligonucleotide Synthesizers Market Size, by Synthesizer Type, 2017-2032 (USD Million)
TABLE 223. France High-throughput Oligonucleotide Synthesizers Market Size, by Throughput, 2017-2032 (USD Million)
TABLE 224. France High-throughput Oligonucleotide Synthesizers Market Size, by Application, 2017-2032 (USD Million)
TABLE 225. France High-throughput Oligonucleotide Synthesizers Market Size, by End User, 2017-2032 (USD Million)
TABLE 226. France High-throughput Oligonucleotide Synthesizers Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 227. Russia High-throughput Oligonucleotide Synthesizers Market Size, 2017-2032 (USD Million)
TABLE 228. Russia High-throughput Oligonucleotide Synthesizers Market Size, by Chemistry, 2017-2032 (USD Million)
TABLE 229. Russia High-throughput Oligonucleotide Synthesizers Market Size, by Modified, 2017-2032 (USD Million)
TABLE 230. Russia High-throughput Oligonucleotide Synthesizers Market Size, by Synthesizer Type, 2017-2032 (USD Million)
TABLE 231. Russia High-throughput Oligonucleotide Synthesizers Market Size, by Throughput, 2017-2032 (USD Million)
TABLE 232. Russia High-throughput Oligonucleotide Synthesizers Market Size, by Application, 2017-2032 (USD Million)
TABLE 233. Russia High-throughput Oligonucleotide Synthesizers Market Size, by End User, 2017-2032 (USD Million)
TABLE 234. Russia High-throughput Oligonucleotide Synthesizers Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 235. Italy High-throughput Oligonucleotide Synthesizers Market Size, 2017-2032 (USD Million)
TABLE 236. Italy High-throughput Oligonucleotide Synthesizers Market Size, by Chemistry, 2017-2032 (USD Million)
TABLE 237. Italy High-throughput Oligonucleotide Synthesizers Market Size, by Modified, 2017-2032 (USD Million)
TABLE 238. Italy High-throughput Oligonucleotide Synthesizers Market Size, by Synthesizer Type, 2017-2032 (USD Million)
TABLE 239. Italy High-throughput Oligonucleotide Synthesizers Market Size, by Throughput, 2017-2032 (USD Million)
TABLE 240. Italy High-throughput Oligonucleotide Synthesizers Market Size, by Application, 2017-2032 (USD Million)
TABLE 241. Italy High-throughput Oligonucleotide Synthesizers Market Size, by End User, 2017-2032 (USD Million)
TABLE 242. Italy High-throughput Oligonucleotide Synthesizers Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 243. Spain High-throughput Oligonucleotide Synthesizers Market Size, 2017-2032 (USD Million)
TABLE 244. Spain High-throughput Oligonucleotide Synthesizers Market Size, by Chemistry, 2017-2032 (USD Million)
TABLE 245. Spain High-throughput Oligonucleotide Synthesizers Market Size, by Modified, 2017-2032 (USD Million)
TABLE 246. Spain High-throughput Oligonucleotide Synthesizers Market Size, by Synthesizer Type, 2017-2032 (USD Million)
TABLE 247. Spain High-throughput Oligonucleotide Synthesizers Market Size, by Throughput, 2017-2032 (USD Million)
TABLE 248. Spain High-throughput Oligonucleotide Synthesizers Market Size, by Application, 2017-2032 (USD Million)
TABLE 249. Spain High-throughput Oligonucleotide Synthesizers Market Size, by End User, 2017-2032 (USD Million)
TABLE 250. Spain High-throughput Oligonucleotide Synthesizers Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 251. China High-throughput Oligonucleotide Synthesizers Market Size, 2017-2032 (USD Million)
TABLE 252. China High-throughput Oligonucleotide Synthesizers Market Size, by Chemistry, 2017-2032 (USD Million)
TABLE 253. China High-throughput Oligonucleotide Synthesizers Market Size, by Modified, 2017-2032 (USD Million)
TABLE 254. China High-throughput Oligonucleotide Synthesizers Market Size, by Synthesizer Type, 2017-2032 (USD Million)
TABLE 255. China High-throughput Oligonucleotide Synthesizers Market Size, by Throughput, 2017-2032 (USD Million)
TABLE 256. China High-throughput Oligonucleotide Synthesizers Market Size, by Application, 2017-2032 (USD Million)
TABLE 257. China High-throughput Oligonucleotide Synthesizers Market Size, by End User, 2017-2032 (USD Million)
TABLE 258. China High-throughput Oligonucleotide Synthesizers Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 259. India High-throughput Oligonucleotide Synthesizers Market Size, 2017-2032 (USD Million)
TABLE 260. India High-throughput Oligonucleotide Synthesizers Market Size, by Chemistry, 2017-2032 (USD Million)
TABLE 261. India High-throughput Oligonucleotide Synthesizers Market Size, by Modified, 2017-2032 (USD Million)
TABLE 262. India High-throughput Oligonucleotide Synthesizers Market Size, by Synthesizer Type, 2017-2032 (USD Million)
TABLE 263. India High-throughput Oligonucleotide Synthesizers Market Size, by Throughput, 2017-2032 (USD Million)
TABLE 264. India High-throughput Oligonucleotide Synthesizers Market Size, by Application, 2017-2032 (USD Million)
TABLE 265. India High-throughput Oligonucleotide Synthesizers Market Size, by End User, 2017-2032 (USD Million)
TABLE 266. India High-throughput Oligonucleotide Synthesizers Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 267. Japan High-throughput Oligonucleotide Synthesizers Market Size, 2017-2032 (USD Million)
TABLE 268. Japan High-throughput Oligonucleotide Synthesizers Market Size, by Chemistry, 2017-2032 (USD Million)
TABLE 269. Japan High-throughput Oligonucleotide Synthesizers Market Size, by Modified, 2017-2032 (USD Million)
TABLE 270. Japan High-throughput Oligonucleotide Synthesizers Market Size, by Synthesizer Type, 2017-2032 (USD Million)
TABLE 271. Japan High-throughput Oligonucleotide Synthesizers Market Size, by Throughput, 2017-2032 (USD Million)
TABLE 272. Japan High-throughput Oligonucleotide Synthesizers Market Size, by Application, 2017-2032 (USD Million)
TABLE 273. Japan High-throughput Oligonucleotide Synthesizers Market Size, by End User, 2017-2032 (USD Million)
TABLE 274. Japan High-throughput Oligonucleotide Synthesizers Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 275. Australia High-throughput Oligonucleotide Synthesizers Market Size, 2017-2032 (USD Million)
TABLE 276. Australia High-throughput Oligonucleotide Synthesizers Market Size, by Chemistry, 2017-2032 (USD Million)
TABLE 277. Australia High-throughput Oligonucleotide Synthesizers Market Size, by Modified, 2017-2032 (USD Million)
TABLE 278. Australia High-throughput Oligonucleotide Synthesizers Market Size, by Synthesizer Type, 2017-2032 (USD Million)
TABLE 279. Australia High-throughput Oligonucleotide Synthesizers Market Size, by Throughput, 2017-2032 (USD Million)
TABLE 280. Australia High-throughput Oligonucleotide Synthesizers Market Size, by Application, 2017-2032 (USD Million)
TABLE 281. Australia High-throughput Oligonucleotide Synthesizers Market Size, by End User, 2017-2032 (USD Million)
TABLE 282. Australia High-throughput Oligonucleotide Synthesizers Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 283. South Korea High-throughput Oligonucleotide Synthesizers Market Size, 2017-2032 (USD Million)
TABLE 284. South Korea High-throughput Oligonucleotide Synthesizers Market Size, by Chemistry, 2017-2032 (USD Million)
TABLE 285. South Korea High-throughput Oligonucleotide Synthesizers Market Size, by Modified, 2017-2032 (USD Million)
TABLE 286. South Korea High-throughput Oligonucleotide Synthesizers Market Size, by Synthesizer Type, 2017-2032 (USD Million)
TABLE 287. South Korea High-throughput Oligonucleotide Synthesizers Market Size, by Throughput, 2017-2032 (USD Million)
TABLE 288. South Korea High-throughput Oligonucleotide Synthesizers Market Size, by Application, 2017-2032 (USD Million)
TABLE 289. South Korea High-throughput Oligonucleotide Synthesizers Market Size, by End User, 2017-2032 (USD Million)
TABLE 290. South Korea High-throughput Oligonucleotide Synthesizers Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 291. Global High-throughput Oligonucleotide Synthesizers Market Share, by Key Player, 2025
TABLE 292. Global High-throughput Oligonucleotide Synthesizers Market, Key Experts

Companies Mentioned

  • Agilent Technologies, Inc.
  • Biolytic Lab Performance, Inc.
  • Bioneer Corporation
  • Biosearch Technologies, Inc.
  • Cantio Bio, Inc.
  • CSBio
  • Cytiva Life Sciences
  • Danaher Corporation
  • DNA Script
  • Eurofins Scientific SE
  • GenScript Biotech Corporation
  • Integrated DNA Technologies, Inc.
  • Kaneka Eurogentec S.A.
  • Kilobaser
  • LGC Limited
  • Merck KGaA
  • Nitto Denko Avecia Inc.
  • OligoMaker ApS
  • PolyGen GmbH
  • Revvity Discovery Limited
  • Sierra BioSystems, Inc.
  • Thermo Fisher Scientific Inc.
  • TriLink BioTechnologies, LLC
  • Twist Bioscience Corporation